Sandy Macrae insider trades
Open-market stock purchases and sales by Sandy Macrae, PRESIDENT, CEO AND DIRECTOR at Sangamo Therapeutics, Inc, from SEC Form 4 filings since Jun 3, 2016.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| May 25, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $2.2K |
| Apr 1, 2026 | SGMO Sangamo Therapeutics, Inc | Bought (not open market) | — |
| Feb 25, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $15.8K |
| Feb 24, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $2.5K |
| Jan 22, 2026 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $41K |
| Nov 24, 2025 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $3.1K |
| Oct 22, 2025 | SGMO Sangamo Therapeutics, Inc | Sold (not open market) | $83.8K |
Companies traded
- SGMO Sangamo Therapeutics, Inc: other filings, last May 25, 2026